FDA inspection
Bayer Healthcare Pharmaceuticals Inc.: FDA inspection ending May 10, 2000
FDA inspection 23605 · Official Action Indicated (OAI) · Whippany, NJ
Key facts
| Inspection ID | 23605 |
|---|---|
| Firm | Bayer Healthcare Pharmaceuticals Inc. |
| FEI number | 2243252 |
| Address | 100 Bayer Blvd |
| City | Whippany |
| State | NJ |
| ZIP | 07981-1544 |
| Fiscal year | 2000 |
| Inspection end date | May 10, 2000 |
| Classification | Official Action Indicated (OAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data